Developmental Funds

西蒙斯综合癌症中心（SCCC）利用癌症中心支持补助金（CCSG） 发展基金投资于支持中心总体战略研究目标的具体工作 计划在本项目期间，CCSG发展基金共计59万美元， 试点资金支持23个研究项目，迄今为止，这些投资已经产生了1600万美元， 投资回报率更重要的是，SCCC高级领导层利用CCSG发展基金 在项目期间与其他中心资源合作。自2014年以来，SCCC总共投资了530万美元用于试点奖励， 这可以直接联系到4870万美元的校外，多年赠款资金的成功奖励。这是 超过九倍的收益在下一个项目期间，SCCC要求41万美元 每年在发展基金中，占CCSG预算要求总额的11%。SCCC高级领导 将继续支持试点项目，但除此之外，它还将支持一个早期阶段高达20%的努力 临床研究者，负责开发和推出创新研究者- 启动试验，并最大限度地提高SCCC在国家癌症研究所的国家临床试验中的参与度 网络

Simmons Comprehensive Cancer Center (SCCC) utilizes the Cancer Center Support Grant (CCSG) developmental funds to invest in specific efforts that support the research goals of the Center’s overall strategic plan. During the current project period, a total of $590,000 of CCSG developmental funds was distributed for pilot funding in support of 23 research projects, and to date these investments have already yielded a $16M return on investment. More importantly, the SCCC Senior Leadership leveraged the CCSG developmental funds with other Center resources during the project period. In total, SCCC invested $5.3M in pilot awards since 2014, which can be directly linked to the successful award of $48.7M in extramural, multi-year grant funding. This is over a nine-fold yield from the combined investment. In the next project period, SCCC is requesting $410,000 annually in developmental funds, representing 11% of the total CCSG budget request. SCCC Senior Leadership will continue to support pilot projects, but in addition it also will be supporting up to 20% effort for one early-stage clinical investigator annually who will be charged with developing and launching an innovative investigator- initiated trial and maximizing SCCC’s participation in the National Cancer Institute’s National Clinical Trials Network.